Cost-Benefit Study of Febrile Neutropenia Prophylactic Treatment with Pegfilgrastim vs. Filgrastim in Pediatric Patients with Solid Tumors

Authors :: Isidoro Tejocote-Romero
Ma. Guadalupe Valois-Escamilla
Cecilia Rodríguez-Castillejos
Norma Araceli López-Facundo
Yanet Jaimes-García
Source :: Gaceta Mexicana de Oncolog�a. 16
Publication Year :: 2022
Publisher :: Publicidad Permanyer, SLU, 2022.

Subjects :: medicine.medical_specialty
business.industry
medicine
Cost benefit
Filgrastim
Intensive care medicine
business
medicine.disease
Pegfilgrastim
Febrile neutropenia
medicine.drug
Prophylactic treatment

Tools